Fig. 1From: Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsDisease-free survival and overall survival in treated patients. Disease-free survival according to stage of the disease in melanoma patients treated with AGI-101H in Trial 3 (a) and Trial 5 (b). Overall survival according to stage of the disease in melanoma patients treated with AGI-101H in Trial 3 (a) and Trial 5 (b)Back to article page